Frontlight ResearchEarly access
Taking people in FinlandPhase 2
Imaging Test for Finding Spread of Pancreatic Cancer to Lymph Nodes
Tests a PET scan using 18F-FAPI-74 to find pancreatic cancer spread in adults.
Key facts
- Who runs it
- Turku University Hospital
- Where
- Turku, FinlandSee the site
- Trial code
- Registry title
- Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Pancreatic Cancer
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 100 people, planned
- Started
- 9 Oct 2024
- Planned end
- 5 Aug 2026
- Type of study
- Interventional
- Record updated
- 20 August 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with pancreatic cancer, or suspected pancreatic cancer, to test how well 18F-FAPI-74 PET/CT scans find cancer spread to nearby lymph nodes.
- Age
- 18-85 years
- Sex
- Men and women
- Disease stage
- Primary or recurrent pancreatic cancer, or suspected primary or recurrent pancreatic cancer
Main reasons for not taking part
- Vulnerable people named in Finnish clinical study law (disabled, children, pregnant or breast-feeding women, prisoners)
- Cannot understand the purpose of the study
- Medical conditions that rule out whole-body PET/CT imaging
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Primary or recurrent pancreatic cancer
- Suspected primary or recurrent pancreatic cancer
- Male or female aged 18-85 years
- WHO performance score 0-2
- Study subject signs informed consent form after receiving written information
Who cannot take part
- Medical conditions prohibiting whole-body PET/CT imaging
- Vulnerable study subjects such as described in Finnish law clinical studies (disabled, children, pregnant or breast-feeding women, prisoners) will not be included
- Study subject is not able to understand the purpose of the study
Where in Finland
- Turku University HospitalTurku, FinlandTaking people
About the trial
What the trial wants to find out
To assess the accuracy of 18F-FAPI-74 PET/CT in detection of local lymph node metastasis in patient level in patients with primary pancreatic cancer.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients with Pancreatic Cancer
- Plain-language title
- Imaging Test for Finding Spread of Pancreatic Cancer to Lymph NodesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 20 August 2024